Direct somatic cell reprogramming: treatment of cardiac diseases

Related Experiment Video

Updated: May 15, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

Chuner Guo1, Kishan Patel, Li Qian

  • 1Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Current Gene Therapy
|January 17, 2013
PubMed

Insights

Directly reprogramming fibroblasts into heart cells offers a promising new approach for cardiac regeneration. This innovative strategy aims to restore heart function after injury, potentially treating heart failure.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Cellular Biology

Background:

  • Cardiac diseases cause significant global morbidity and mortality.
  • Cardiomyocyte death leads to irreversible damage and scar tissue formation, impairing heart function and causing heart failure.
  • Adult human hearts possess limited regenerative capacity.

Purpose of the Study:

  • To review the history, recent advances, and challenges in cellular reprogramming for cardiac regeneration.
  • To explore the potential of direct reprogramming of fibroblasts into cardiomyocyte-like cells for therapeutic applications.

Main Methods:

  • Review of existing literature on cellular reprogramming techniques.
  • Focus on methods utilizing transcription factors and microRNAs for cardiac reprogramming.
  • Analysis of in vitro and in vivo studies demonstrating reprogramming efficacy.

Main Results:

  • Promising advances in directly reprogramming mouse fibroblasts into cardiomyocyte-like cells.
  • Demonstrated improvements in heart function in mouse models of myocardial infarction via in vivo reprogramming.
  • Identification of transcription factors and microRNAs as key reprogramming tools.

Conclusions:

  • Cardiac reprogramming holds exciting potential for regenerative therapies in patients with heart disease.
  • While still in early stages, this field presents numerous novel research directions.
  • Further research is crucial to overcome challenges and translate these findings into clinical applications.

More Related Videos

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...